|
TULP4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.556300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.842300E-02 |
| Normal-vs-Stage2 |
8.818400E-01 |
| Normal-vs-Stage3 |
3.982700E-04 |
| Normal-vs-Stage4 |
9.70869999999957E-05 |
| Stage1-vs-Stage2 |
4.466200E-02 |
| Stage1-vs-Stage3 |
8.057800E-02 |
| Stage1-vs-Stage4 |
7.263700E-03 |
| Stage2-vs-Stage3 |
5.678800E-03 |
| Stage2-vs-Stage4 |
9.181900E-04 |
| Stage3-vs-Stage4 |
2.982200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.645500E-04 |
| Normal-vs-AfricanAmerican |
9.521400E-01 |
| Normal-vs-Asian |
3.639700E-03 |
| Caucasian-vs-AfricanAmerican |
2.103900E-02 |
| Caucasian-vs-Asian |
7.065600E-01 |
| AfricanAmerican-vs-Asian |
2.451500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.079800E-02 |
| Normal-vs-Female |
4.177200E-03 |
| Male-vs-Female |
7.390400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.237990E-02 |
| Normal-vs-Age(41-60Yrs) |
6.439400E-03 |
| Normal-vs-Age(61-80Yrs) |
3.123900E-02 |
| Normal-vs-Age(81-100Yrs) |
4.821900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.708200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.169400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.879000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.277000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.434200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.436800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.869700E-02 |
| Classical-VS-Follicular |
5.881900E-03 |
| Classical-VS-Other |
8.585800E-01 |
| Classical-VS-Normal |
1.724240E-03 |
| Tall-VS-Follicular |
3.963800E-04 |
| Tall-VS-Other |
2.592800E-01 |
| Tall-VS-Normal |
2.755200E-04 |
| Follicular-VS-Other |
4.573400E-01 |
| Follicular-VS-Normal |
8.514800E-01 |
| Other-VS-Normal |
3.117200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.792400E-02 |
| Normal-vs-N1 |
1.58652999999731E-05 |
| N0-vs-N1 |
2.588900E-04 |
|
|
